Our data support the hypothesis that SEPT9 isoforms maintain functional differences that could be selected for during tumor development and indicate that SEPT9 isoform profiling could lead to the development of additional biomarkers for breast cancer detection, prognosis and treatment. This evidence concerns the gene SEPTIN9 and neoplasm.